Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bey

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomasF Eschwège, H Sancho-Garnier, D Chassagne, et al.
Journal of Medicinal Chemistry|December 23, 1994
Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketonesM R Angelastro, L E Baugh, P Bey, et al.
British Journal of Cancer|May 18, 2001
SOR: project methodologyB Fervers, J Hardy, M P Blanc-Vincent, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary resultsP Bey, C Carrie, V Beckendorf, et al.
Biosensors & Bioelectronics|December 5, 1998
Description and demonstration of a CMOS amplifier-based-system with measurement and stimulation capability for bioelectrical signal transductionJ J Pancrazio, P P Bey, A Loloee, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 18, 2003
[Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: experience of French dose-escalation trials]V Beckendorf, J M Bachaud, P Bey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 1, 1997
[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases]B Cutuli, A de La Rochefordière, F Dhermain, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patientsB Cutuli, F Dhermain, C Borel, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
British Journal of Cancer|May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC Le Tourneau, B Dreno, Y Kirova, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomasF Eschwège, H Sancho-Garnier, D Chassagne, et al.
Journal of Medicinal Chemistry|December 23, 1994
Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketonesM R Angelastro, L E Baugh, P Bey, et al.
British Journal of Cancer|May 18, 2001
SOR: project methodologyB Fervers, J Hardy, M P Blanc-Vincent, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary resultsP Bey, C Carrie, V Beckendorf, et al.
Biosensors & Bioelectronics|December 5, 1998
Description and demonstration of a CMOS amplifier-based-system with measurement and stimulation capability for bioelectrical signal transductionJ J Pancrazio, P P Bey, A Loloee, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 18, 2003
[Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: experience of French dose-escalation trials]V Beckendorf, J M Bachaud, P Bey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 1, 1997
[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases]B Cutuli, A de La Rochefordière, F Dhermain, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patientsB Cutuli, F Dhermain, C Borel, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
British Journal of Cancer|May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC Le Tourneau, B Dreno, Y Kirova, et al.
Pageof 18